The worldwide market size for Scaffold Technology Market is estimated to grow at a CAGR of 11.45% during 2017 and 2025. Scaffold technology is a part of tissue engineering and has a regenerative medical application. Scaffold technology basically works on the principles of cell biology. Scaffold technology helps the cell in maintaining three-dimensional architectures that permits the formation of new tissues. Moreover, scaffold technology is influenced by the interactions between the cells and the extracellular matrix during normal tissue developments. This technology is an effective and simple approach that aid in achieving desirable in vitro and in vivo tissue regeneration within the synthetic polymeric scaffolds. In recent years, the usage of electrospinning as a fabrication method has widely increased as it generates nanofibers with a diameter range of several nanometers and various tissue application.
The global scaffold technology market is primarily driven by continuous technology advancements, continuous evolution of tissue engineering with its increasing application in developing biological substitutes for replacement, and need for regeneration of the diseased or defective organs and tissues. Additionally, high adoption of 3D cell culture models, and its utilization of this technology for overcoming the deficits of the 2D cell culture for various drug developments & discovery process and its increasing demand to influence the market growth. Similarly, the key companies are playing an important role in developing innovative stem-cell substrates that help in developing new regenerative medicines, drug discovery studies, and disease & organogenesis modeling supporting the growth. However, some failures that are associated with the 3D cell culture models to impede the market growth during the forecast period.
North America Scaffold Technology Market by Application, 2017 - 2025
Inside circle shows data for 2017 and outer circle shows data for 2025
The global scaffold technology market is segmented on the basis of product, application, end use and geography.
On the basis of product type, the scaffold technology market is segmented as polymeric scaffolds, hydrogels, micropatterned surface microplates, freeze embryo testing, and nanofiber-based scaffolds. Hydrogels segment accounted for the highest market share owing to the factors such as its ease of loading cells and drugs for controlled drug delivery. In addition, biocompatibility and integration of hydrogels with the host tissue are responsible for its growth. On the other hand, these hydrogels are similar to the native tissues and are insoluble which add-on for the growth of its market during the forecast period.
Based on application, the scaffold technology market is segmented as drug development, stem cell research, cancer, tissue engineering and clinical application, and others. Cancer application to account for the largest market share in the scaffold technology market. The growth of this segment is majorly driven due to the factors such as the increasing number of populations suffering from various types of cancer. Additionally, the high success rate of 3D cell culture modeling in cancer research, and increasing adoption of a combination of stem cells & scaffold technology, and increased success rate to also drive the segment growth.
On the basis of end use, the scaffold technology market is segmented as research laboratories & institutes, biotechnology and pharmaceutical organizations, hospital & diagnostics center, and others. Biotechnology and pharmaceutical organizations accounted for the largest market share-owning to the factors such as increasing investment on research and development by the manufacturers. Moreover, increasing funding by the governments and well-regulated systems has also promoted the growth of this market in the foreseeable future.
North America Scaffold Technology Market by Application type, 2017 - 2025 (USD Million)
By geography, the global scaffold technology market is segmented into five major regions, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In terms of geography, North America dominates the scaffold technology market. The growth of this market is majorly driven by the increasing number of patients suffering from various types of cancer, and an increasing number of deaths due to cancer. According to WHO, cancer is the second leading cause of death globally that accounted for 8.8 million of deaths in 2015 would also influence the market growth. Additionally, increasing investment by the government and regional players for to also support the market growth with the continuous increase in the research and development for the use of this technology. Whereas, Asia-Pacific is expected to grow at a faster rate owing to the continuous increase in the investments on developing healthcare infrastructure by the governments due to highly regulated policies for promoting the use of this technology, increasing number of patients suffering from cancer, and raising awareness for the use of organ transplant. Furthermore, the rising number of smoking population in this region, and increasing alcohol consumption due to changing lifestyle to also drive the scaffold technology market in Asia-Pacific.
Some of the major key players operating in global scaffold technology market are Merck and Company, Thermo Fisher Scientific Inc., 3D Biotek LLC, Pelo Biotech GmbH, Corning Inc., Becton, Dickinson and Company, Avacta Life Sciences Limited, Nanofiber Solutions, NuVasive, Inc., ReproCELL Europe Ltd., Marticel GmbH, Tecan Trading AG, and Molecular Matrix Inc.